Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 674 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Jazz announces new formulation patent for Xyrem

Xyrem (sodium oxybate) oral solution is the FDA approved product for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy. The new patent entitled

CbaySystems renames as M*Modal Global Services

The renaming allows uniting several healthcare IT brands under the single name "M*Modal" to supply Speech Understanding and Natural Language Understanding technologies. M*Modal chairman and CEO Vern Davenport